China Approves First Domestic 9-Valent HPV Vaccine
China approves its first domestically developed 9-valent HPV vaccine, a major step in public health and medical innovation offering broader protection against cervical cancer.
Biotech
Read More
Chinese Innovators Revolutionize Drug Delivery with Organ ‘Band-Aid’
Chinese scientists unveil precision drug-delivery ‘organ band-aid’ using nano-tech, published in Nature. A potential game-changer for healthcare.
23andMe Seeks Buyer Amid Bankruptcy Filing, Data Concerns Rise
Genetic testing firm 23andMe files for bankruptcy amid data security concerns and customer attrition, signaling challenges for consumer biotech.